Hanmi licenses cancer asset from Rapt Therapeutics
Korean company Hanmi Pharmaceutical has signed a licence and collaboration agreement with US-based Rapt Therapeutics...
Read More...
Focus:
South-korea
-
![Boehringer forms alliance with Bridge Biotherapeutics for IPF drug]()
Boehringer forms alliance with Bridge Biotherapeutics for IPF drug
Boehringer Ingelheim has entered a collaboration and licence agreement to develop South Korea-based Bridge Biotherapeutics’...
Read More...
-
![Dundee University partners Bukwang to develop Parkinson’s drug]()
Dundee University and Bukwang to develop Parkinson’s drug
The University of Dundee's drug discovery unit (DDU) has formed an alliance with Korea-based Bukwang...
Read More...
-
![Boehringer partners with Yuhan on liver disease drug]()
Boehringer partners with Yuhan for liver disease drug
Boehringer Ingelheim has partnered with South Korea-based Yuhan for the development of a first-in-class compound...
Read More...
-
Deals this week: Mundipharma, Ligand Pharmaceuticals
Mundipharma has signed an agreement with Kolon Life Sciences to secure rights for osteoarthritis therapy...
Read More...
-
![SAL200]()
Roivant and iNtRON sign licensing deal for SAL200
Roivant Sciences and iNtRON Biotechnology have signed a $667.5m global licensing agreement for SAL200, which...
Read More...
-
![]()
South Korean regulator publishes final ruling on Samsung BioLogics’ accounting violations
South Korea’s financial regulator Securities and Futures Commission (SFC) has issued its final decision regarding...
Read More...
-
![Yuhan]()
Yuhan licences lung cancer asset to Janssen in $1.25bn deal
South Korean pharmaceutical company Yuhan has signed a licensing and cooperation agreement valued at up...
Read More...
-
M&As this week: JW Pharmaceutical, Lonza, Karo Intressenter
JW Pharmaceutical has acquired a 25% stake in Argonaut Therapeutics through a $2.6m investment.
Read More...
-
JW Pharmaceutical invests in British anti-cancer drugs developer
South Korea-based pharmaceutical products company JW Pharmaceutical has invested $2.6m in British anti-cancer drugs developer...
Read More...
Close
Close
Close
Go Top
